Form 4: Tenet Healthcare COO Sells 8,000 Shares
Insider Trading Report
Lisa Y. Foo, Executive Vice President and Chief Operating Officer of Tenet Healthcare Corp, sold 8,000 shares of common stock for a weighted average price of $179.53 per share under a Rule 10b5-1 trading plan.
Summary
- Lisa Y. Foo, Executive Vice President and Chief Operating Officer of Tenet Healthcare Corp (THC), reported a sale of common stock.
- The transaction involved the disposition of 8,000 shares of common stock.
- The shares were sold on August 20, 2025, at a weighted average price of $179.53 per share.
- The sales occurred in multiple transactions with prices ranging from $179.22 to $179.74.
- Following this transaction, Lisa Y. Foo beneficially owns 20,878 shares of common stock directly.
- The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
Sentiment
Score: 4
Explanation: The sale of shares by a high-ranking executive is generally viewed with slight negativity by the market, as it could signal a lack of confidence. However, the transaction being executed under a Rule 10b5-1 plan mitigates some of this concern, indicating a pre-scheduled sale rather than a reaction to immediate negative news.
Negatives
- An executive selling a significant number of shares (8,000 shares, approximately $1.44 million) could be perceived as a lack of confidence in the company's near-term prospects, although this is mitigated by the Rule 10b5-1 plan.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Disclosure | The transaction was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, which allows insiders to set up a pre-arranged plan to buy or sell company stock to avoid accusations of insider trading. | 08/20/2025 | Enhances transparency and provides an affirmative defense against insider trading allegations, as the plan is established when the insider is not in possession of material non-public information. |
Stakeholder Impact
- Shareholders: May interpret the sale as a slight negative signal regarding the company's short-term prospects, though the 10b5-1 plan mitigates this to some extent.
Key Dates
| Date | Description |
|---|---|
| 08/20/2025 | Date of earliest transaction (sale of common stock) |
| 08/22/2025 | Date Form 4 was filed |
Recommendation
holdWhile insider selling can sometimes be a bearish signal, this transaction was conducted under a Rule 10b5-1 plan, suggesting it was pre-scheduled and not necessarily indicative of new negative information. The sale represents a portion of the executive's holdings, and without further context on the company's performance or other insider activity, a 'hold' recommendation is appropriate to monitor future developments.
Keywords
Tenet Healthcare, THC, Insider Trading, Form 4, Executive Stock Sale, Lisa Y. Foo, 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.